An Observational Study of Cardiac Events in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin.

Trial Profile

An Observational Study of Cardiac Events in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Aug 2017

At a glance

  • Drugs Trastuzumab (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 04 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 26 Jan 2015 Planned End Date changed from 1 Apr 2016 to 1 May 2016 as reported by ClinicalTrials.gov.
    • 26 Jan 2015 Planned primary completion date changed from 1 Apr 2016 to 1 May 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top